• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


National Resilience Expands West Chester, Ohio, Biomanufacturing Operations

National Resilience, Inc., a technology-focused biomanufacturing company, plans to expand its operations in West Chester, Ohio. The $228.9 million project is expected to create 274 jobs over the next three years.

“After completing our purchase of the West Chester manufacturing site in January 2023, Resilience remains committed to the state of Ohio and we are thrilled to both further develop and modernize the facility and grow our West Chester workforce,” said Rahul Singhvi, Sc.D., Chief Executive Officer of Resilience. “Our West Chester facility plays a key role within Resilience’s network, as the site serves as our global center of excellence for commercial drug product manufacturing.”

Resilience is a technology company dedicated to broadening access to complex medicines and to protecting biopharmaceutical supply chains against disruption. The company is building a sustainable network of high-tech, end-to-end manufacturing solutions to help ensure the medicines of today and tomorrow can be made quickly, safely and at scale.

“Resilience’s West Chester expansion builds additional manufacturing capacity and a more resilient supply chain, further strengthening Ohio’s life sciences sector,” noted J.P. Nauseef, JobsOhio president and CEO. “By nearly doubling its presence in West Chester, Resilience can continue advancing a mission of revolutionizing the way novel medicines are developed and manufactured.”

“Resilience adding more than 400 jobs to the region supports our well-established life sciences industry, spanning nearly 1,100 business locations from startups to homegrown companies,” added Kimm Lauterbach, REDI Cincinnati president and CEO. “With a job growth rate of 25% over the last five years and 17,000 workers, this announcement further solidifies the Cincinnati region as the center of health innovation coupled with our world-class research universities and medical institutions.”

Exclusive Research